nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitroglycerin—GUCY1A2—myometrium—ovarian cancer	0.0229	0.0501	CbGeAlD
Nitroglycerin—GUCY1A2—uterine cervix—ovarian cancer	0.0178	0.039	CbGeAlD
Nitroglycerin—GUCY1A3—myometrium—ovarian cancer	0.0144	0.0316	CbGeAlD
Nitroglycerin—GUCY1B3—myometrium—ovarian cancer	0.0143	0.0313	CbGeAlD
Nitroglycerin—NPR1—myometrium—ovarian cancer	0.0134	0.0293	CbGeAlD
Nitroglycerin—GUCY1A2—female reproductive system—ovarian cancer	0.0134	0.0292	CbGeAlD
Nitroglycerin—ALDH2—myometrium—ovarian cancer	0.0122	0.0266	CbGeAlD
Nitroglycerin—GUCY1A3—uterine cervix—ovarian cancer	0.0112	0.0246	CbGeAlD
Nitroglycerin—GUCY1B3—uterine cervix—ovarian cancer	0.0111	0.0244	CbGeAlD
Nitroglycerin—GUCY1A2—testis—ovarian cancer	0.0108	0.0236	CbGeAlD
Nitroglycerin—GUCY1A3—decidua—ovarian cancer	0.0107	0.0234	CbGeAlD
Nitroglycerin—GUCY1B3—decidua—ovarian cancer	0.0106	0.0232	CbGeAlD
Nitroglycerin—NPR1—epithelium—ovarian cancer	0.0105	0.023	CbGeAlD
Nitroglycerin—NPR1—uterine cervix—ovarian cancer	0.0104	0.0228	CbGeAlD
Nitroglycerin—GUCY1A3—endometrium—ovarian cancer	0.0102	0.0222	CbGeAlD
Nitroglycerin—GUCY1B3—endometrium—ovarian cancer	0.0101	0.0221	CbGeAlD
Nitroglycerin—NPR1—decidua—ovarian cancer	0.00993	0.0217	CbGeAlD
Nitroglycerin—ALDH2—uterine cervix—ovarian cancer	0.00946	0.0207	CbGeAlD
Nitroglycerin—NPR1—endometrium—ovarian cancer	0.00943	0.0206	CbGeAlD
Nitroglycerin—GUCY1A3—uterus—ovarian cancer	0.00936	0.0205	CbGeAlD
Nitroglycerin—GUCY1B3—uterus—ovarian cancer	0.00929	0.0203	CbGeAlD
Nitroglycerin—ALDH2—decidua—ovarian cancer	0.00902	0.0197	CbGeAlD
Nitroglycerin—NPR1—uterus—ovarian cancer	0.00869	0.019	CbGeAlD
Nitroglycerin—ALDH2—endometrium—ovarian cancer	0.00856	0.0187	CbGeAlD
Nitroglycerin—GUCY1A3—female reproductive system—ovarian cancer	0.00841	0.0184	CbGeAlD
Nitroglycerin—GUCY1B3—female reproductive system—ovarian cancer	0.00835	0.0183	CbGeAlD
Nitroglycerin—GUCY1A3—bone marrow—ovarian cancer	0.00794	0.0174	CbGeAlD
Nitroglycerin—ALDH2—gonad—ovarian cancer	0.00794	0.0174	CbGeAlD
Nitroglycerin—ALDH2—uterus—ovarian cancer	0.00789	0.0173	CbGeAlD
Nitroglycerin—GUCY1B3—bone marrow—ovarian cancer	0.00788	0.0172	CbGeAlD
Nitroglycerin—GUCY1A2—lymph node—ovarian cancer	0.00781	0.0171	CbGeAlD
Nitroglycerin—NPR1—female reproductive system—ovarian cancer	0.00781	0.0171	CbGeAlD
Nitroglycerin—GUCY1A3—female gonad—ovarian cancer	0.00766	0.0167	CbGeAlD
Nitroglycerin—GUCY1A3—vagina—ovarian cancer	0.00761	0.0166	CbGeAlD
Nitroglycerin—GUCY1B3—female gonad—ovarian cancer	0.0076	0.0166	CbGeAlD
Nitroglycerin—GUCY1B3—vagina—ovarian cancer	0.00755	0.0165	CbGeAlD
Nitroglycerin—NPR1—female gonad—ovarian cancer	0.00711	0.0155	CbGeAlD
Nitroglycerin—ALDH2—female reproductive system—ovarian cancer	0.00709	0.0155	CbGeAlD
Nitroglycerin—NPR1—vagina—ovarian cancer	0.00707	0.0155	CbGeAlD
Nitroglycerin—GUCY1A3—testis—ovarian cancer	0.00679	0.0149	CbGeAlD
Nitroglycerin—GUCY1B3—testis—ovarian cancer	0.00674	0.0147	CbGeAlD
Nitroglycerin—ALDH2—bone marrow—ovarian cancer	0.00669	0.0146	CbGeAlD
Nitroglycerin—ALDH2—female gonad—ovarian cancer	0.00645	0.0141	CbGeAlD
Nitroglycerin—ALDH2—vagina—ovarian cancer	0.00641	0.014	CbGeAlD
Nitroglycerin—NPR1—testis—ovarian cancer	0.0063	0.0138	CbGeAlD
Nitroglycerin—ALDH2—testis—ovarian cancer	0.00572	0.0125	CbGeAlD
Nitroglycerin—GUCY1A3—lymph node—ovarian cancer	0.00492	0.0108	CbGeAlD
Nitroglycerin—GUCY1B3—lymph node—ovarian cancer	0.00489	0.0107	CbGeAlD
Nitroglycerin—NPR1—lymph node—ovarian cancer	0.00457	0.01	CbGeAlD
Nitroglycerin—ALDH2—lymph node—ovarian cancer	0.00415	0.00907	CbGeAlD
Nitroglycerin—Oedema peripheral—Paclitaxel—ovarian cancer	0.0013	0.0024	CcSEcCtD
Nitroglycerin—Pruritus—Chlorambucil—ovarian cancer	0.0013	0.00239	CcSEcCtD
Nitroglycerin—Urticaria—Topotecan—ovarian cancer	0.0013	0.00239	CcSEcCtD
Nitroglycerin—Abdominal pain—Topotecan—ovarian cancer	0.00129	0.00237	CcSEcCtD
Nitroglycerin—Body temperature increased—Topotecan—ovarian cancer	0.00129	0.00237	CcSEcCtD
Nitroglycerin—Visual impairment—Paclitaxel—ovarian cancer	0.00127	0.00234	CcSEcCtD
Nitroglycerin—Coma—Doxorubicin—ovarian cancer	0.00127	0.00234	CcSEcCtD
Nitroglycerin—Urticaria—Melphalan—ovarian cancer	0.00127	0.00234	CcSEcCtD
Nitroglycerin—Paraesthesia—Vinorelbine—ovarian cancer	0.00125	0.00231	CcSEcCtD
Nitroglycerin—Infestation—Docetaxel—ovarian cancer	0.00125	0.0023	CcSEcCtD
Nitroglycerin—Infestation NOS—Docetaxel—ovarian cancer	0.00125	0.0023	CcSEcCtD
Nitroglycerin—Dyspnoea—Vinorelbine—ovarian cancer	0.00124	0.00229	CcSEcCtD
Nitroglycerin—Flushing—Paclitaxel—ovarian cancer	0.00123	0.00226	CcSEcCtD
Nitroglycerin—Cardiac disorder—Paclitaxel—ovarian cancer	0.00123	0.00226	CcSEcCtD
Nitroglycerin—Stomatitis—Docetaxel—ovarian cancer	0.00122	0.00224	CcSEcCtD
Nitroglycerin—Eczema—Epirubicin—ovarian cancer	0.00121	0.00224	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.0012	0.00222	CcSEcCtD
Nitroglycerin—Hypersensitivity—Topotecan—ovarian cancer	0.0012	0.00221	CcSEcCtD
Nitroglycerin—Angiopathy—Paclitaxel—ovarian cancer	0.0012	0.00221	CcSEcCtD
Nitroglycerin—Immune system disorder—Paclitaxel—ovarian cancer	0.00119	0.0022	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Paclitaxel—ovarian cancer	0.00119	0.00219	CcSEcCtD
Nitroglycerin—Renal failure acute—Epirubicin—ovarian cancer	0.00118	0.00218	CcSEcCtD
Nitroglycerin—Arrhythmia—Paclitaxel—ovarian cancer	0.00118	0.00217	CcSEcCtD
Nitroglycerin—Hypersensitivity—Melphalan—ovarian cancer	0.00118	0.00217	CcSEcCtD
Nitroglycerin—Asthenia—Topotecan—ovarian cancer	0.00117	0.00216	CcSEcCtD
Nitroglycerin—Hot flush—Epirubicin—ovarian cancer	0.00117	0.00215	CcSEcCtD
Nitroglycerin—Vomiting—Chlorambucil—ovarian cancer	0.00116	0.00215	CcSEcCtD
Nitroglycerin—Mental disorder—Paclitaxel—ovarian cancer	0.00116	0.00213	CcSEcCtD
Nitroglycerin—Menopausal symptoms—Epirubicin—ovarian cancer	0.00116	0.00213	CcSEcCtD
Nitroglycerin—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.00116	0.00213	CcSEcCtD
Nitroglycerin—Pruritus—Topotecan—ovarian cancer	0.00115	0.00213	CcSEcCtD
Nitroglycerin—Erythema—Paclitaxel—ovarian cancer	0.00115	0.00212	CcSEcCtD
Nitroglycerin—Feeling abnormal—Vinorelbine—ovarian cancer	0.00115	0.00212	CcSEcCtD
Nitroglycerin—Asthenia—Melphalan—ovarian cancer	0.00115	0.00211	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00114	0.0021	CcSEcCtD
Nitroglycerin—Pruritus—Melphalan—ovarian cancer	0.00113	0.00208	CcSEcCtD
Nitroglycerin—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.00113	0.00208	CcSEcCtD
Nitroglycerin—Eczema—Doxorubicin—ovarian cancer	0.00112	0.00207	CcSEcCtD
Nitroglycerin—Rhinitis—Docetaxel—ovarian cancer	0.00112	0.00207	CcSEcCtD
Nitroglycerin—Pharyngitis—Docetaxel—ovarian cancer	0.00111	0.00205	CcSEcCtD
Nitroglycerin—Urticaria—Vinorelbine—ovarian cancer	0.00111	0.00204	CcSEcCtD
Nitroglycerin—Abdominal pain—Vinorelbine—ovarian cancer	0.0011	0.00203	CcSEcCtD
Nitroglycerin—Body temperature increased—Vinorelbine—ovarian cancer	0.0011	0.00203	CcSEcCtD
Nitroglycerin—Oedema peripheral—Docetaxel—ovarian cancer	0.0011	0.00203	CcSEcCtD
Nitroglycerin—Renal failure acute—Doxorubicin—ovarian cancer	0.00109	0.00201	CcSEcCtD
Nitroglycerin—Nausea—Chlorambucil—ovarian cancer	0.00109	0.002	CcSEcCtD
Nitroglycerin—Vision blurred—Paclitaxel—ovarian cancer	0.00108	0.002	CcSEcCtD
Nitroglycerin—Hot flush—Doxorubicin—ovarian cancer	0.00108	0.00199	CcSEcCtD
Nitroglycerin—Visual impairment—Docetaxel—ovarian cancer	0.00108	0.00199	CcSEcCtD
Nitroglycerin—Dizziness—Topotecan—ovarian cancer	0.00108	0.00199	CcSEcCtD
Nitroglycerin—Menopausal symptoms—Doxorubicin—ovarian cancer	0.00107	0.00197	CcSEcCtD
Nitroglycerin—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.00107	0.00197	CcSEcCtD
Nitroglycerin—Agitation—Paclitaxel—ovarian cancer	0.00106	0.00195	CcSEcCtD
Nitroglycerin—Angioedema—Paclitaxel—ovarian cancer	0.00105	0.00193	CcSEcCtD
Nitroglycerin—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.00104	0.00192	CcSEcCtD
Nitroglycerin—Flushing—Docetaxel—ovarian cancer	0.00104	0.00191	CcSEcCtD
Nitroglycerin—Cardiac disorder—Docetaxel—ovarian cancer	0.00104	0.00191	CcSEcCtD
Nitroglycerin—Vomiting—Topotecan—ovarian cancer	0.00104	0.00191	CcSEcCtD
Nitroglycerin—Vertigo—Paclitaxel—ovarian cancer	0.00103	0.0019	CcSEcCtD
Nitroglycerin—Syncope—Paclitaxel—ovarian cancer	0.00103	0.0019	CcSEcCtD
Nitroglycerin—Rash—Topotecan—ovarian cancer	0.00103	0.00189	CcSEcCtD
Nitroglycerin—Hypersensitivity—Vinorelbine—ovarian cancer	0.00103	0.00189	CcSEcCtD
Nitroglycerin—Dermatitis—Topotecan—ovarian cancer	0.00103	0.00189	CcSEcCtD
Nitroglycerin—Headache—Topotecan—ovarian cancer	0.00102	0.00188	CcSEcCtD
Nitroglycerin—Palpitations—Paclitaxel—ovarian cancer	0.00102	0.00187	CcSEcCtD
Nitroglycerin—Angiopathy—Docetaxel—ovarian cancer	0.00102	0.00187	CcSEcCtD
Nitroglycerin—Vomiting—Melphalan—ovarian cancer	0.00102	0.00187	CcSEcCtD
Nitroglycerin—Immune system disorder—Docetaxel—ovarian cancer	0.00101	0.00186	CcSEcCtD
Nitroglycerin—Loss of consciousness—Paclitaxel—ovarian cancer	0.00101	0.00186	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Docetaxel—ovarian cancer	0.00101	0.00186	CcSEcCtD
Nitroglycerin—Rash—Melphalan—ovarian cancer	0.00101	0.00185	CcSEcCtD
Nitroglycerin—Dermatitis—Melphalan—ovarian cancer	0.00101	0.00185	CcSEcCtD
Nitroglycerin—Asthenia—Vinorelbine—ovarian cancer	0.001	0.00184	CcSEcCtD
Nitroglycerin—Arrhythmia—Docetaxel—ovarian cancer	0.001	0.00184	CcSEcCtD
Nitroglycerin—Orthostatic hypotension—Epirubicin—ovarian cancer	0.000997	0.00184	CcSEcCtD
Nitroglycerin—Pruritus—Vinorelbine—ovarian cancer	0.000987	0.00182	CcSEcCtD
Nitroglycerin—Mental disorder—Docetaxel—ovarian cancer	0.000981	0.00181	CcSEcCtD
Nitroglycerin—Erythema—Docetaxel—ovarian cancer	0.000974	0.00179	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000972	0.00179	CcSEcCtD
Nitroglycerin—Nausea—Topotecan—ovarian cancer	0.000968	0.00178	CcSEcCtD
Nitroglycerin—Nausea—Melphalan—ovarian cancer	0.000948	0.00175	CcSEcCtD
Nitroglycerin—Confusional state—Paclitaxel—ovarian cancer	0.000946	0.00174	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000938	0.00173	CcSEcCtD
Nitroglycerin—Infection—Paclitaxel—ovarian cancer	0.000932	0.00172	CcSEcCtD
Nitroglycerin—Shock—Paclitaxel—ovarian cancer	0.000923	0.0017	CcSEcCtD
Nitroglycerin—Dizziness—Vinorelbine—ovarian cancer	0.000922	0.0017	CcSEcCtD
Nitroglycerin—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000922	0.0017	CcSEcCtD
Nitroglycerin—Nervous system disorder—Paclitaxel—ovarian cancer	0.00092	0.00169	CcSEcCtD
Nitroglycerin—Angina pectoris—Epirubicin—ovarian cancer	0.000919	0.00169	CcSEcCtD
Nitroglycerin—Tachycardia—Paclitaxel—ovarian cancer	0.000916	0.00169	CcSEcCtD
Nitroglycerin—Skin disorder—Paclitaxel—ovarian cancer	0.000911	0.00168	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000907	0.00167	CcSEcCtD
Nitroglycerin—Vomiting—Vinorelbine—ovarian cancer	0.000887	0.00163	CcSEcCtD
Nitroglycerin—Rash—Vinorelbine—ovarian cancer	0.000879	0.00162	CcSEcCtD
Nitroglycerin—Dermatitis—Vinorelbine—ovarian cancer	0.000879	0.00162	CcSEcCtD
Nitroglycerin—Hypotension—Paclitaxel—ovarian cancer	0.000877	0.00161	CcSEcCtD
Nitroglycerin—Headache—Vinorelbine—ovarian cancer	0.000874	0.00161	CcSEcCtD
Nitroglycerin—Syncope—Docetaxel—ovarian cancer	0.000874	0.00161	CcSEcCtD
Nitroglycerin—Palpitations—Docetaxel—ovarian cancer	0.000861	0.00159	CcSEcCtD
Nitroglycerin—Loss of consciousness—Docetaxel—ovarian cancer	0.000856	0.00158	CcSEcCtD
Nitroglycerin—Angina pectoris—Doxorubicin—ovarian cancer	0.00085	0.00157	CcSEcCtD
Nitroglycerin—Paraesthesia—Paclitaxel—ovarian cancer	0.000842	0.00155	CcSEcCtD
Nitroglycerin—Infestation—Epirubicin—ovarian cancer	0.000841	0.00155	CcSEcCtD
Nitroglycerin—Drowsiness—Epirubicin—ovarian cancer	0.000841	0.00155	CcSEcCtD
Nitroglycerin—Infestation NOS—Epirubicin—ovarian cancer	0.000841	0.00155	CcSEcCtD
Nitroglycerin—Dyspnoea—Paclitaxel—ovarian cancer	0.000836	0.00154	CcSEcCtD
Nitroglycerin—Somnolence—Paclitaxel—ovarian cancer	0.000834	0.00154	CcSEcCtD
Nitroglycerin—Nausea—Vinorelbine—ovarian cancer	0.000828	0.00153	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000824	0.00152	CcSEcCtD
Nitroglycerin—Stomatitis—Epirubicin—ovarian cancer	0.00082	0.00151	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00081	0.00149	CcSEcCtD
Nitroglycerin—Sweating—Epirubicin—ovarian cancer	0.000806	0.00149	CcSEcCtD
Nitroglycerin—Confusional state—Docetaxel—ovarian cancer	0.000802	0.00148	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Docetaxel—ovarian cancer	0.000795	0.00146	CcSEcCtD
Nitroglycerin—Infection—Docetaxel—ovarian cancer	0.00079	0.00146	CcSEcCtD
Nitroglycerin—Shock—Docetaxel—ovarian cancer	0.000782	0.00144	CcSEcCtD
Nitroglycerin—Nervous system disorder—Docetaxel—ovarian cancer	0.00078	0.00144	CcSEcCtD
Nitroglycerin—Infestation NOS—Doxorubicin—ovarian cancer	0.000778	0.00143	CcSEcCtD
Nitroglycerin—Infestation—Doxorubicin—ovarian cancer	0.000778	0.00143	CcSEcCtD
Nitroglycerin—Drowsiness—Doxorubicin—ovarian cancer	0.000778	0.00143	CcSEcCtD
Nitroglycerin—Tachycardia—Docetaxel—ovarian cancer	0.000776	0.00143	CcSEcCtD
Nitroglycerin—Feeling abnormal—Paclitaxel—ovarian cancer	0.000773	0.00142	CcSEcCtD
Nitroglycerin—Skin disorder—Docetaxel—ovarian cancer	0.000772	0.00142	CcSEcCtD
Nitroglycerin—Bradycardia—Epirubicin—ovarian cancer	0.000769	0.00142	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000767	0.00141	CcSEcCtD
Nitroglycerin—Stomatitis—Doxorubicin—ovarian cancer	0.000758	0.0014	CcSEcCtD
Nitroglycerin—Rhinitis—Epirubicin—ovarian cancer	0.000757	0.00139	CcSEcCtD
Nitroglycerin—Pharyngitis—Epirubicin—ovarian cancer	0.000749	0.00138	CcSEcCtD
Nitroglycerin—Sweating—Doxorubicin—ovarian cancer	0.000746	0.00137	CcSEcCtD
Nitroglycerin—Urticaria—Paclitaxel—ovarian cancer	0.000745	0.00137	CcSEcCtD
Nitroglycerin—Oedema peripheral—Epirubicin—ovarian cancer	0.000744	0.00137	CcSEcCtD
Nitroglycerin—Hypotension—Docetaxel—ovarian cancer	0.000743	0.00137	CcSEcCtD
Nitroglycerin—Abdominal pain—Paclitaxel—ovarian cancer	0.000742	0.00137	CcSEcCtD
Nitroglycerin—Body temperature increased—Paclitaxel—ovarian cancer	0.000742	0.00137	CcSEcCtD
Nitroglycerin—Visual impairment—Epirubicin—ovarian cancer	0.000727	0.00134	CcSEcCtD
Nitroglycerin—Paraesthesia—Docetaxel—ovarian cancer	0.000714	0.00132	CcSEcCtD
Nitroglycerin—Bradycardia—Doxorubicin—ovarian cancer	0.000711	0.00131	CcSEcCtD
Nitroglycerin—Dyspnoea—Docetaxel—ovarian cancer	0.000709	0.00131	CcSEcCtD
Nitroglycerin—Somnolence—Docetaxel—ovarian cancer	0.000707	0.0013	CcSEcCtD
Nitroglycerin—Flushing—Epirubicin—ovarian cancer	0.000701	0.00129	CcSEcCtD
Nitroglycerin—Cardiac disorder—Epirubicin—ovarian cancer	0.000701	0.00129	CcSEcCtD
Nitroglycerin—Rhinitis—Doxorubicin—ovarian cancer	0.0007	0.00129	CcSEcCtD
Nitroglycerin—Pharyngitis—Doxorubicin—ovarian cancer	0.000693	0.00128	CcSEcCtD
Nitroglycerin—Hypersensitivity—Paclitaxel—ovarian cancer	0.000691	0.00127	CcSEcCtD
Nitroglycerin—Oedema peripheral—Doxorubicin—ovarian cancer	0.000688	0.00127	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000686	0.00126	CcSEcCtD
Nitroglycerin—Angiopathy—Epirubicin—ovarian cancer	0.000685	0.00126	CcSEcCtD
Nitroglycerin—Immune system disorder—Epirubicin—ovarian cancer	0.000682	0.00126	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Epirubicin—ovarian cancer	0.00068	0.00125	CcSEcCtD
Nitroglycerin—Arrhythmia—Epirubicin—ovarian cancer	0.000674	0.00124	CcSEcCtD
Nitroglycerin—Visual impairment—Doxorubicin—ovarian cancer	0.000673	0.00124	CcSEcCtD
Nitroglycerin—Asthenia—Paclitaxel—ovarian cancer	0.000673	0.00124	CcSEcCtD
Nitroglycerin—Pruritus—Paclitaxel—ovarian cancer	0.000664	0.00122	CcSEcCtD
Nitroglycerin—Mental disorder—Epirubicin—ovarian cancer	0.000661	0.00122	CcSEcCtD
Nitroglycerin—Erythema—Epirubicin—ovarian cancer	0.000657	0.00121	CcSEcCtD
Nitroglycerin—Feeling abnormal—Docetaxel—ovarian cancer	0.000655	0.00121	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00065	0.0012	CcSEcCtD
Nitroglycerin—Flushing—Doxorubicin—ovarian cancer	0.000648	0.00119	CcSEcCtD
Nitroglycerin—Cardiac disorder—Doxorubicin—ovarian cancer	0.000648	0.00119	CcSEcCtD
Nitroglycerin—Angiopathy—Doxorubicin—ovarian cancer	0.000634	0.00117	CcSEcCtD
Nitroglycerin—Immune system disorder—Doxorubicin—ovarian cancer	0.000631	0.00116	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Doxorubicin—ovarian cancer	0.00063	0.00116	CcSEcCtD
Nitroglycerin—Body temperature increased—Docetaxel—ovarian cancer	0.000629	0.00116	CcSEcCtD
Nitroglycerin—Abdominal pain—Docetaxel—ovarian cancer	0.000629	0.00116	CcSEcCtD
Nitroglycerin—Arrhythmia—Doxorubicin—ovarian cancer	0.000624	0.00115	CcSEcCtD
Nitroglycerin—Dizziness—Paclitaxel—ovarian cancer	0.00062	0.00114	CcSEcCtD
Nitroglycerin—Vision blurred—Epirubicin—ovarian cancer	0.000619	0.00114	CcSEcCtD
Nitroglycerin—Mental disorder—Doxorubicin—ovarian cancer	0.000612	0.00113	CcSEcCtD
Nitroglycerin—Erythema—Doxorubicin—ovarian cancer	0.000608	0.00112	CcSEcCtD
Nitroglycerin—Agitation—Epirubicin—ovarian cancer	0.000604	0.00111	CcSEcCtD
Nitroglycerin—Vomiting—Paclitaxel—ovarian cancer	0.000596	0.0011	CcSEcCtD
Nitroglycerin—Rash—Paclitaxel—ovarian cancer	0.000591	0.00109	CcSEcCtD
Nitroglycerin—Dermatitis—Paclitaxel—ovarian cancer	0.000591	0.00109	CcSEcCtD
Nitroglycerin—Vertigo—Epirubicin—ovarian cancer	0.00059	0.00109	CcSEcCtD
Nitroglycerin—Syncope—Epirubicin—ovarian cancer	0.000589	0.00109	CcSEcCtD
Nitroglycerin—Headache—Paclitaxel—ovarian cancer	0.000588	0.00108	CcSEcCtD
Nitroglycerin—Hypersensitivity—Docetaxel—ovarian cancer	0.000586	0.00108	CcSEcCtD
Nitroglycerin—Palpitations—Epirubicin—ovarian cancer	0.000581	0.00107	CcSEcCtD
Nitroglycerin—Loss of consciousness—Epirubicin—ovarian cancer	0.000578	0.00106	CcSEcCtD
Nitroglycerin—Vision blurred—Doxorubicin—ovarian cancer	0.000573	0.00106	CcSEcCtD
Nitroglycerin—Asthenia—Docetaxel—ovarian cancer	0.00057	0.00105	CcSEcCtD
Nitroglycerin—Pruritus—Docetaxel—ovarian cancer	0.000563	0.00104	CcSEcCtD
Nitroglycerin—Agitation—Doxorubicin—ovarian cancer	0.000559	0.00103	CcSEcCtD
Nitroglycerin—Nausea—Paclitaxel—ovarian cancer	0.000557	0.00103	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000556	0.00102	CcSEcCtD
Nitroglycerin—Vertigo—Doxorubicin—ovarian cancer	0.000546	0.00101	CcSEcCtD
Nitroglycerin—Syncope—Doxorubicin—ovarian cancer	0.000545	0.001	CcSEcCtD
Nitroglycerin—Confusional state—Epirubicin—ovarian cancer	0.000541	0.000996	CcSEcCtD
Nitroglycerin—Palpitations—Doxorubicin—ovarian cancer	0.000537	0.00099	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Epirubicin—ovarian cancer	0.000536	0.000988	CcSEcCtD
Nitroglycerin—Loss of consciousness—Doxorubicin—ovarian cancer	0.000534	0.000985	CcSEcCtD
Nitroglycerin—Infection—Epirubicin—ovarian cancer	0.000533	0.000982	CcSEcCtD
Nitroglycerin—Shock—Epirubicin—ovarian cancer	0.000528	0.000972	CcSEcCtD
Nitroglycerin—Nervous system disorder—Epirubicin—ovarian cancer	0.000526	0.000969	CcSEcCtD
Nitroglycerin—Dizziness—Docetaxel—ovarian cancer	0.000526	0.000969	CcSEcCtD
Nitroglycerin—Tachycardia—Epirubicin—ovarian cancer	0.000523	0.000964	CcSEcCtD
Nitroglycerin—Skin disorder—Epirubicin—ovarian cancer	0.000521	0.00096	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Epirubicin—ovarian cancer	0.000518	0.000955	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000514	0.000947	CcSEcCtD
Nitroglycerin—Vomiting—Docetaxel—ovarian cancer	0.000506	0.000931	CcSEcCtD
Nitroglycerin—Rash—Docetaxel—ovarian cancer	0.000501	0.000924	CcSEcCtD
Nitroglycerin—Hypotension—Epirubicin—ovarian cancer	0.000501	0.000923	CcSEcCtD
Nitroglycerin—Dermatitis—Docetaxel—ovarian cancer	0.000501	0.000923	CcSEcCtD
Nitroglycerin—Confusional state—Doxorubicin—ovarian cancer	0.0005	0.000922	CcSEcCtD
Nitroglycerin—Headache—Docetaxel—ovarian cancer	0.000498	0.000918	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000496	0.000914	CcSEcCtD
Nitroglycerin—Infection—Doxorubicin—ovarian cancer	0.000493	0.000908	CcSEcCtD
Nitroglycerin—Shock—Doxorubicin—ovarian cancer	0.000488	0.000899	CcSEcCtD
Nitroglycerin—Nervous system disorder—Doxorubicin—ovarian cancer	0.000487	0.000897	CcSEcCtD
Nitroglycerin—Tachycardia—Doxorubicin—ovarian cancer	0.000484	0.000892	CcSEcCtD
Nitroglycerin—Skin disorder—Doxorubicin—ovarian cancer	0.000482	0.000888	CcSEcCtD
Nitroglycerin—Paraesthesia—Epirubicin—ovarian cancer	0.000482	0.000887	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Doxorubicin—ovarian cancer	0.00048	0.000884	CcSEcCtD
Nitroglycerin—Dyspnoea—Epirubicin—ovarian cancer	0.000478	0.000881	CcSEcCtD
Nitroglycerin—Somnolence—Epirubicin—ovarian cancer	0.000477	0.000878	CcSEcCtD
Nitroglycerin—Nausea—Docetaxel—ovarian cancer	0.000472	0.00087	CcSEcCtD
Nitroglycerin—Hypotension—Doxorubicin—ovarian cancer	0.000464	0.000854	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000463	0.000853	CcSEcCtD
Nitroglycerin—Paraesthesia—Doxorubicin—ovarian cancer	0.000446	0.000821	CcSEcCtD
Nitroglycerin—Dyspnoea—Doxorubicin—ovarian cancer	0.000442	0.000815	CcSEcCtD
Nitroglycerin—Feeling abnormal—Epirubicin—ovarian cancer	0.000442	0.000814	CcSEcCtD
Nitroglycerin—Somnolence—Doxorubicin—ovarian cancer	0.000441	0.000813	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000439	0.000808	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000428	0.000789	CcSEcCtD
Nitroglycerin—Urticaria—Epirubicin—ovarian cancer	0.000426	0.000785	CcSEcCtD
Nitroglycerin—Abdominal pain—Epirubicin—ovarian cancer	0.000424	0.000781	CcSEcCtD
Nitroglycerin—Body temperature increased—Epirubicin—ovarian cancer	0.000424	0.000781	CcSEcCtD
Nitroglycerin—Feeling abnormal—Doxorubicin—ovarian cancer	0.000409	0.000753	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000406	0.000748	CcSEcCtD
Nitroglycerin—Hypersensitivity—Epirubicin—ovarian cancer	0.000395	0.000728	CcSEcCtD
Nitroglycerin—Urticaria—Doxorubicin—ovarian cancer	0.000394	0.000726	CcSEcCtD
Nitroglycerin—Body temperature increased—Doxorubicin—ovarian cancer	0.000392	0.000723	CcSEcCtD
Nitroglycerin—Abdominal pain—Doxorubicin—ovarian cancer	0.000392	0.000723	CcSEcCtD
Nitroglycerin—Asthenia—Epirubicin—ovarian cancer	0.000385	0.000709	CcSEcCtD
Nitroglycerin—Pruritus—Epirubicin—ovarian cancer	0.000379	0.000699	CcSEcCtD
Nitroglycerin—Hypersensitivity—Doxorubicin—ovarian cancer	0.000366	0.000674	CcSEcCtD
Nitroglycerin—Asthenia—Doxorubicin—ovarian cancer	0.000356	0.000656	CcSEcCtD
Nitroglycerin—Dizziness—Epirubicin—ovarian cancer	0.000355	0.000653	CcSEcCtD
Nitroglycerin—Pruritus—Doxorubicin—ovarian cancer	0.000351	0.000647	CcSEcCtD
Nitroglycerin—Vomiting—Epirubicin—ovarian cancer	0.000341	0.000628	CcSEcCtD
Nitroglycerin—Rash—Epirubicin—ovarian cancer	0.000338	0.000623	CcSEcCtD
Nitroglycerin—Dermatitis—Epirubicin—ovarian cancer	0.000338	0.000622	CcSEcCtD
Nitroglycerin—Headache—Epirubicin—ovarian cancer	0.000336	0.000619	CcSEcCtD
Nitroglycerin—Dizziness—Doxorubicin—ovarian cancer	0.000328	0.000605	CcSEcCtD
Nitroglycerin—Nausea—Epirubicin—ovarian cancer	0.000319	0.000587	CcSEcCtD
Nitroglycerin—Vomiting—Doxorubicin—ovarian cancer	0.000316	0.000581	CcSEcCtD
Nitroglycerin—Rash—Doxorubicin—ovarian cancer	0.000313	0.000576	CcSEcCtD
Nitroglycerin—Dermatitis—Doxorubicin—ovarian cancer	0.000313	0.000576	CcSEcCtD
Nitroglycerin—Headache—Doxorubicin—ovarian cancer	0.000311	0.000573	CcSEcCtD
Nitroglycerin—Nausea—Doxorubicin—ovarian cancer	0.000295	0.000543	CcSEcCtD
